| 000 | 01550 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514200600.0 | ||
| 264 | 0 | _c20050324 | |
| 008 | 200503s 0 0 eng d | ||
| 022 | _a0960-894X | ||
| 024 | 7 |
_a10.1016/j.bmcl.2004.07.024 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTownes, Jennifer A | |
| 245 | 0 | 0 |
_aThe development of new bicyclic pyrazole-based cytokine synthesis inhibitors. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cOct 2004 |
||
| 300 |
_a4945-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 |
_aPyrazoles _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xantagonists & inhibitors |
| 700 | 1 | _aGolebiowski, Adam | |
| 700 | 1 | _aClark, Michael P | |
| 700 | 1 | _aLaufersweiler, Matthew J | |
| 700 | 1 | _aBrugel, Todd A | |
| 700 | 1 | _aSabat, Mark | |
| 700 | 1 | _aBookland, Roger G | |
| 700 | 1 | _aLaughlin, Steve K | |
| 700 | 1 | _aVanRens, John C | |
| 700 | 1 | _aDe, Biswanath | |
| 700 | 1 | _aHsieh, Lily C | |
| 700 | 1 | _aXu, Susan C | |
| 700 | 1 | _aJanusz, Michael J | |
| 700 | 1 | _aWalter, Richard L | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 14 _gno. 19 _gp. 4945-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2004.07.024 _zAvailable from publisher's website |
| 999 |
_c15039006 _d15039006 |
||